EGFR and melanoma: In addition, our phosphoproteomic studies identified activation of ErbB signaling as a top hit in IFNγR1KO melanoma, which is known to feed signals into the PI3K-Akt-mTOR pathway32 and may represent a potential underlying mechanism of mTOR activation.